MedRythyms – a Portland-based digital therapeutics company has signed a lucrative deal with pharmaceutical giant Biogen to bring its music therapy offering designed to improve walking in people with multiple sclerosis a step closer to reality.
MedRythyms – a Portland-based digital therapeutics company has signed a lucrative deal with pharmaceutical giant Biogen to bring its music therapy offering designed to improve walking in people with multiple sclerosis a step closer to reality.